Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Ronidazole in the Treatment of Trichomonad Infections in Cats

Author(s):  Davidson Gigi S

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Page(s):  434-435

Ronidazole in the Treatment of Trichomonad Infections in Cats Page 1
Ronidazole in the Treatment of Trichomonad Infections in Cats Page 2

Download in electronic PDF format for $75

Abstract:  Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been identified. Since recommended dosages of antimicrobial drugs have failed in cats infected with Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr. Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be

Related Keywords: Gigi S Davison, BS, RPh, FSVHP, DICVP, cats, Tritrichomonas foetus, trichomonad infection, protozoa, parasites, parasitic infection, ronidazole, antibiotics, antimicrobial agent, antiparasitic agent, diarrhea, adverse effects, side effects, drug safety, neurotoxicity, nystagmus, ataxia, behavioral disorders, dosage forms, dosing, veterinary


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
Nov/Dec 2006
Pg. 434-435

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
Nov/Dec 2011
Pg. 450-457

Aztreonam Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 60

Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study
Curtis Larry
, Biundo Bruce
May/Jun 2001
Pg. 195

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
Sep/Oct 2006
Pg. 324-328

A Review of Stomatitis and Treatment in Cats
Ray Jody D
, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
Sep/Oct 2009
Pg. 372-381

Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
Sep/Oct 2002
Pg. 338-343

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
May/Jun 2022
Pg. 238

Wiping Out Diaper Rash
Fields Shannon W
Nov/Dec 2005
Pg. 433-434

View Sample
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Compounding for Feline Herpetic Keratitis
Davidson Gigi S
Nov/Dec 2006
Pg. 411-414

Benzoate or Not to Benzoate: Cats Are the Question, To
Davidson Gigi S
Mar/Apr 2001
Pg. 89-90

View Sample
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 282-285

Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 60

Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
Jan/Feb 2003
Pg. 10-15

View Sample
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Return to Top